About 20,000 diabetologists will attend the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), to be held in Barcelona1
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive and life-threatening disease. The Hospital Clínic of Barcelona is a refe1
Dr. Josep Dalmau is an ICREA investigator leading the IDIBAPS Autoimmunity against synaptic antigens Group. His international impact is reflected in1
Early treatment of asymptomatic high-risk smoldering myeloma could significantly improve the course of disease, slowing its progression and significa1
Chronic liver failure is among the top ten causes of death in adults in many countries and constitutes the most common reason for hospital admission1
Two members of the IDIBAPS Clinical and Experimental Respiratory Immunoallergy team (IRCE), the predoctoral researcher Francisco de Borja Callejas Dí1
The search for a reliable way to diagnose Alzheimer's disease is one of the great challenges of modern biomedicine. IDIBAPS-IIBB-CSIC Neurobiology Un1
Catalonia is becoming one of the main knowledge centers in the Mediterranean. To facilitate this process, Barcelona Centre Universitari (BCU) helps f1
About a third of people infected with HIV in the USA and Europe are also infected with hepatitis C virus (HCV). A work published in The Lancet Infect1
